South Africa · Medical and donor conditions

A microscope and blank clinical review papers in a modern consultation room
Editorial illustration only; it is not evidence of a real clinic, legal approval or treatment.

South Africa surrogacy: medical and donor requirements

The short answer

South African surrogacy has two connected but different gates: the Children’s Act controls whether a surrogacy agreement can be confirmed, while health legislation and clinical judgment govern assisted reproduction and donor gametes. The statute does not contain one exhaustive medical checklist for every person. It does require proof that the commissioning parent or parents cannot give birth to a child because of a permanent and irreversible condition, and it requires the court to assess the surrogate’s suitability and the interests of the child. Donor screening rules are more technical, but the current status of later proposed regulations and the effect of a constitutional judgment must be checked before treatment. [S1–S5]

Medical condition of the commissioning parent

Under section 295(a) of the Children’s Act 38 of 2005, the High Court may not confirm an agreement unless the commissioning parent or parents are unable to give birth to a child and that condition is permanent and irreversible. The Act does not prescribe a closed list of diagnoses or say that one particular test is sufficient. The relevant evidence must explain the individual medical circumstances and why the inability is permanent and irreversible; a general statement that surrogacy is preferred is not the statutory test. The court also considers whether the intended parent or parents are competent and suitable to accept parenthood and understand the legal consequences. [S1]

Statutory conditions for the surrogate

Section 295(c) requires the surrogate to be competent to enter the agreement, suitable in all respects, and to understand her rights and obligations. She must not be using surrogacy as a source of income and must act for altruistic, not commercial, purposes. The Act also expressly requires a documented history of at least one pregnancy and viable delivery, and a living child of her own. These are statutory conditions, not optional clinic preferences. A previous pregnancy alone does not establish present medical fitness; the court must still assess the individual facts and the welfare of the child to be born. [S1]

The genetic-link rule and donor gametes

Section 294 sets a strict genetic-origin rule. Normally, both commissioning parents’ gametes are to be used. If that is not possible for biological, medical or other valid reasons, the gamete of at least one commissioning parent must be used. Where there is a single commissioning parent, that person’s gamete must be used. A donor may therefore provide the other gamete where the legal conditions are met, but donor sperm and donor eggs cannot simply replace every commissioning parent’s genetic contribution under this section. In 2024 the Supreme Court of Appeal upheld the genetic-link requirement; do not assume an exception for a genetically linked sibling or for a family’s preferred embryo plan. [S1, S6]

Court confirmation must precede fertilisation

Under section 292, the written, signed surrogacy agreement needs High Court confirmation. The same section sets domicile and court-jurisdiction conditions; section 293 also addresses written consent and participation by spouses or partners, with a limited exception for unreasonably withheld consent by the surrogate’s spouse or partner who is not the child’s genetic parent. Section 292 separately allows the court, on good cause, to dispense with the surrogate’s domicile requirement. A clinic cannot waive those legal requirements. Section 296 bars artificial fertilisation of the surrogate mother before confirmation and after 18 months from it. A pending application is not authorisation to transfer an embryo to, or inseminate, the surrogate. Earlier steps need separate analysis: regulation 10(2)(a) of the 2012 text links IVF to a specific recipient. In Ex parte MCM (2022) the High Court refused advance IVF where no recipient had been identified. A later challenge to that regulation was dismissed in 2024 on procedural grounds without deciding its constitutionality. These decisions do not grant general permission for pre-confirmation embryo creation; equally, section 296 alone does not prohibit every instance of ovarian stimulation or gamete retrieval. If embryos already exist, document their origin, identified recipient, consents and storage, and obtain individual South African legal advice before proceeding. [S1, S2, S9, S10]

For territorial eligibility and court venue, section 292 also requires the agreement to be entered into in South Africa, at least one commissioning parent (or the sole commissioning parent) to be domiciled there when entering the agreement, and confirmation by the High Court for the area where the commissioning parent or parents are domiciled or habitually resident. The surrogate and her spouse or partner, if any, generally must also be domiciled in South Africa at that time; only the surrogate-side domicile requirement may be dispensed with by the court for good cause. Under section 293, the commissioning parent's spouse or permanent partner must give written consent and become a party; the surrogate's spouse or permanent partner normally must do the same, subject to the narrow exception for unreasonable refusal by a non-genetic spouse or partner. Check domicile, venue and signed consents before filing. [S1]

Medical and psychological evidence for court

The Act requires suitability but does not list every report that must be filed in every case. In Ex parte WH, the High Court said the application should include full medical reports on the surrogate’s physical condition and risks to her or the child, specifically addressing HIV status and diseases that could be transmitted to the child. It also called for a comprehensive psychologist’s report on the surrogate’s background, psychological profile and the likely effect of surrogacy and handing over the baby. Later decisions, including Ex parte KAF, stress careful, individual scrutiny rather than a rubber-stamp approach. Treat these judgments as important court guidance, not as a substitute for checking the practice directions and evidence requirements of the division hearing the case. [S3, S4]

Donor screening under the 2012 regulation text

The Regulations Relating to Artificial Fertilisation of Persons published in 2012 (R175) set out detailed donor safeguards. They require a donor file and central-data-bank reporting, informed consent to examination and processing, a signed statement about earlier donations, and verification of the donor’s age. The text requires tests for sexually transmissible diseases on two occasions, no more than three months apart, with the relevant testing one month before donation; a male donor must also have a semen analysis. A female donor must have a gynaecological examination before stimulation. The competent person must take a family history, including possible genetic conditions, carrier status and mental illness in close relatives. These are regulatory requirements in the 2012 text; do not substitute a clinic’s short marketing checklist for the full record. [S2] The 2012 text also prohibits use of a gamete from a donor under 18 years old except where there is a medical indication.

Genetic risk, consent and clinical records

The 2012 regulations also require attention to genetically transmissible conditions. Where a serious genetic condition is in issue, the recipient and donor must be tested as required by the regulation; a donor gamete must not be used in the specified circumstances where the donor is a carrier. A family history suggesting a transmissible disorder triggers further examination or testing and appropriate information for the recipient or treating professional. The recipient must give informed consent to examination and treatment, and the clinic must keep records of medical tests, genetic evaluation, donor information and relevant consent. Ask for a written explanation of any identified carrier risk and for genetic counselling where appropriate; do not treat a donor profile as a guarantee that a child will have no genetic condition. [S2] The rules also require a recipient file and records of the recipient’s tests for sexually transmissible infections or communicable diseases, genetic evaluation, and psychological or social suitability evaluation if indicated; in a surrogacy arrangement, the recipient is generally the woman carrying the embryo.

Donor limits, confidentiality and reimbursement

Under regulation 6 of the 2012 text, a competent person must not take further gametes from a donor if they know or suspect that six children have been conceived using that donor’s gametes, and must report relevant information to the central data bank. The regulations require donor records to be retained and restrict disclosure except as allowed by law or court order. A gamete donor may be reimbursed for reasonable expenses incurred in donating; this is not a licence to buy gametes. The donor-gamete rules are distinct from the Children’s Act rules on permissible expenses in a surrogacy arrangement. Because later proposed texts use different donor limits, confirm the operative regulation and the clinic’s central-data-bank process in writing before choosing a donor. [S1, S2, S7, S8] The text also calls for destruction of stored gametes after six children conceived using a donor’s gametes have been born alive, unless the Minister consents to retention.

Known donors, embryo transfer and the 2022 constitutional order

The 2012 regulation text required written confirmation where donor and recipient knew each other and a psychological evaluation of both. In Surrogacy Advisory Group v Minister of Health (2022), the High Court declared the psychological-evaluation requirement unconstitutional and invalid, suspended that declaration for 24 months, and directed that an exception for married couples or permanent domestic life-partners be read in during the suspension; the order said the reading-in would become final if the defect was not remedied in time. The same judgment addressed the old regulation on sex selection, with a 12-month suspension and a direction that the provision be struck if the defect was not cured. The post-deadline legislative response and any later court orders have not been published. A South African lawyer should confirm the current effect before relying on either provision. Separately, regulation 12 of the 2012 text permits transfer of no more than three zygotes or embryos in one procedure unless a specific medical indication requires otherwise. [S2, S5]

What is law, court practice or clinic policy?

Keep three categories separate. First, the Children’s Act’s permanent-and-irreversible condition, genetic-link rule, prior viable delivery and living-child requirements are statutory. Second, court decisions describe the medical and psychological evidence needed to decide suitability, but the precise filing package can vary with the facts and the High Court division. Third, clinics may impose stricter clinical acceptance criteria, such as age bands, BMI limits, uterine assessments, additional infection tests or their own donor screening protocols. Unless a requirement is tied to a verified statute, binding judgment or official direction, ask the clinic to identify it as policy and provide the written rule. A clinic’s willingness to treat is not the same as court confirmation or legal eligibility. [S1–S5]

Documents to assemble before committing to treatment

Ask South African counsel and the reproductive specialist to prepare a coordinated file: (1) a specialist report explaining the commissioning parent’s permanent and irreversible inability to give birth; (2) the surrogate’s obstetric history, proof of a prior viable delivery and proof of a living child; (3) a current medical report assessing physical fitness to carry the pregnancy and risks to the surrogate and child, including HIV and transmissible disease; (4) the required psychological reports and any supporting collateral information; (5) donor consent, prior-donation statement, infection-test results, semen analysis or gynaecological examination as relevant, family history and genetic results; (6) records identifying the source of each gamete and confirming the section 294 genetic link; and (7) the written surrogacy agreement and proposed court papers. The list is a preparation guide, not a guarantee that a court will require no further evidence. [S1–S4]

Safe sequence and practical next steps

Before selecting a donor or paying for a treatment cycle, ask the clinic to identify the legal basis for each mandatory test, age limit, donor cap and embryo-transfer rule, and to distinguish legislation from clinic policy. Ask for the donor-screening protocol and confirmation of how donation history is checked against the central data bank. Have counsel verify the current status of the 2012 regulations, the 2022 constitutional order and any later Gazette amendments; the 2016 and 2021 documents cited here include proposed or draft text and should not be treated automatically as operative law. Then assemble the medical and psychological evidence, finalise the written agreement and obtain High Court confirmation before artificial fertilisation. Recheck the 18-month limit if treatment is delayed. Ask counsel separately to check whether gamete retrieval, IVF or cryopreservation is permissible for the actual identified recipient before the court order; never infer authorisation from a pending application. [S1–S5, S7, S8, S9, S10]

Bottom line and review limits

The practical decision is not simply whether a clinic accepts the intended parents or a donor. The intended parents need evidence of permanent and irreversible inability to give birth; the surrogate must meet the statutory prior-pregnancy and living-child requirements and be medically and psychologically suitable; at least one intended parent must provide a gamete; and the agreement must be confirmed before artificial fertilisation of the surrogate. Donor testing, genetic risk, records and limits must be addressed under the applicable health rules. [S1–S8]

Sources and legal materials

  1. Children’s Act 38 of 2005 (official text) [S1]
  2. Regulations Relating to Artificial Fertilisation of Persons, GN R175 (2 March 2012) [S2]
  3. Ex parte WH and Others (2011) [2011] ZAGPPHC 185 [S3]
  4. Ex parte KAF and Others (2018) [2018] ZAGPJHC 529 [S4]
  5. Surrogacy Advisory Group v Minister of Health (2022) [2022] ZAGPPHC 558 [S5]
  6. KB & Another v Minister of Social Development (2024) [2024] ZASCA 54 [S6]
  7. 2016 publication concerning proposed amendments to the artificial-fertilisation regulations [S7]
  8. Draft Regulations Relating to Assisted Conception of Persons, 2020, GN 251 (25 March 2021) [S8]
  9. Ex parte MCM and Another (2022) [2022] ZAGPPHC 712 [S9]
  10. Surrogacy Advisory Group NPC v Minister of Health (2024) [2024] ZAGPPHC 431 [S10]

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards